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GENERAL INTRODUCTION 
Leuconostoc mesenteroides B-512F dextransucrase , an 
industrially important enzyme, synthesizes dextran using the 
glucosyl part of sucrose as shown below: 
Dextransucrase 
n Sucrose > Dextran + n Fructose 
B-512F dextran has 95% a (1-6) linkages and 5% 0(1-3) branch 
linkages^ (see Fig. 1) . Dextrans have been used to make 
Sephadex and blood plasma substitute^. Recently a solution of 
dextran with a molecular weight of 40,000 has been used for 
the preservation of livers for transplantation^ The 
molecular weight of dextran largely depends on the 
concentration of sucrose used, and low concentration of 
sucrose produces high molecular weight dextran"'. 
In addition to sucrose, it was found that a-D-glucopyranosyl 
fluoride® and p-nitrophenyl-a-D-glucopyranoside® are also 
substrates for dextransucrase. The enzyme has a molecular 
weight of 177-195 kDa'^'®. It is composed of three monomers^ and 
the monomer is 65 kDa. The pH optimum of the purified enzyme 
is 5.0-5.5' and the isoelectric point of dextran-free enzyme 
is 4.0®. The enzyme is stabilized by its product, dextran''^. 
Normally dextransucrase catalyzes the formation of dextran by 
polymerization of the glucosyl part of sucrose, but acceptor 
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reactions take place when carbohydrates other than sucrose are 
added to sucrose-dextransucrase digests. In acceptor 
reactions, some of the glucosyl groups of sucrose molecules 
are transferred to the carbohydrate*", which is called an 
acceptor. Acceptor reactions lead to formation of 
oligosaccharides and decreased synthesis of dextran. There 
are many carbohydrates which act as acceptors'-. The acceptor 
reactions of dextransucrase have been used industrially for 
the production of controlled molecular weight dextran*^ and 
leucrose", a-D-glucopyranosyl-(1-5)-D-fructopyranose. 
The mechanism of biosynthesis of dextran has been studied 
by several investigators^''"'-®. The mechanism proposed by Robyt 
et al^® is generally accepted in the field (see Fig. 2). This 
mechanism proposes that dextran synthesis proceeds by a two-
site insertion mechanism in which covalent glucosyl and 
dexranosyl enzyme intermediates are formed, and the glucosyl 
unit is added to the reducing-end of the growing dextran 
chain. 
Explanation of dissertation format 
This dissertation consists of three papers, the first two 
of which have been published. The process described in the 
third paper will be patented. References for each paper are 
given at the end of the paper. References for the general 
introduction and literature review are listed under the 
additional references after the general summary. 
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LITERATURE REVIEW 
Mechanism of dextran biosynthesis 
There have been many arguments concerning the mechanism 
of the biosynthesis of dextran by dextransucrase since there 
are two possible mechanisms for the biosynthesis of linear 
polysaccharides'". In the first mechanism, the repeating units 
are added sequentially to the nonreducing end of a growing 
chain, but in the second mechanism, the repeating units are 
added sequentially to the reducing end by insertion between a 
carrier and the growing chain. 
A mechanism for the biosynthesis of dextran should 
consist of the following: how the biosynthesis starts, how a 
dextran chain grows (i.e., from reducing end or nonreducing 
end), how the branching occurs, and how dextran is released 
from the enzyme. 
Hehre^^ suggested that the growth of dextran chains is a 
stepwise propagative reaction where glucosyl group of a 
sucrose molecule is transferred to nonreducing end of a 
growing dextran chain. A dextran primer is required in this 
mechanism. As of 1993, all of the dextransucrase preparations 
contained some dextran due to the fact that dextransucrase is 
induced by sucrose, and sucrose must be present in the growth 
medium, and therefore sucrose acts as a substrate for the 
enzyme in the biosynthesis of dextran. Recently in our 
laboratory, a constitutive mutant of Leuconostoc mesenteroides 
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B-512FM that produced dextransucrase from a glucose medium was 
obtained". The dextransucrase secreted by this mutant 
bacterium didn't have any dextran contamination, but it still 
synthesized dextran using sucrose, indicating the mechanism 
suggested by Hehre is not correct, that is, dextran primer is 
not required. 
Tsuchiya-' and Neely''' proposed that the dextran chain 
grows from its nonreducing end. They also proposed that 
sucrose serves as glucosyl donor and acceptor in the beginning 
of the dextran synthesis, thus a glucose unit is transferred 
to glucosyl part of another sucrose molecule forming 
isomaltosyl fructoside. They proposed that subsequent 
transfer of glucose units to isomaltosyl fructoside eventually 
leads to the formation of dextran chains. Isomaltosyl 
fructoside, the first compound formed in the mechanisms 
proposed by Tsuchiya and Neely, was synthesized and reacted 
with dextransucrase in the presence of sucrose^^'^®. This 
compound inhibited dextran synthesis and caused the formation 
of oligosaccharides showing that the mechanisms proposed by 
Tsuchiya and Neely were not correct. 
Ebert and Schenk^^ proposed an insertion mechanism for 
dextran biosynthesis, where glucose groups of sucrose 
molecules are added to the reducing end of the growing dextran 
chain. They did not present any direct experimental evidence, 
and their mechanism was based primarily on the logical 
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interpretation of the acceptor reactions. 
Finally long awaited evidence about dextransucrase action 
was presented by Robyt et al'S showing that dextran is 
synthesized by dextransucrase by the transfer of glucose from 
sucrose to the reducing end of a growing dextran chain. In 
the mechanism proposed (see Fig. 2), dextransucrase has two 
nucleophilic catalytic groups which attack sucrose to give 
glucosyl complexes through carbon of glucose. Then, C^-OH 
of one of these glucose units makes a nucleophilic attack onto 
the of the other glucose unit forming an a-(1-6) glucosidic 
linkage and releasing the nucleophile, which forms a new 
enzyme-glucosyl complex by attacking another sucrose molecule. 
The Cg-OH of this newly formed glucosyl unit then attacks C-_ of 
the isomaltosyl group forming isomaltotriosyl-enzyme complex. 
As long as sucrose is available, the process continues with 
the catalytic groups alternatively forming covalent complexes 
with glucose and the growing dextran chain. Dextran chain 
growth will be stopped when an acceptor reaction takes place 
between an acceptor,e.g fructose or glucose, and the enzyme-
dextranosyl complex leading to release of the dextran from the 
enzyme. If dextran is the acceptor, then, this acceptor 
reaction forms branch linkages in dextran". 
B-512FM dextran has 5% a-(l->3) branch linkages and some 
of the branches are one glucose unit long, others are longer 
(see Fig. 1). To explain the branching in dextran, different 
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mechanisms were proposed: It was suggested that a branching 
enzyme is responsible for the formation of branches". Bovey" 
proposed that branches are formed in dextran by glucosyl 
transfer from sucrose molecule to the C3-OH group of an a-
(1-6) linked chain. Successive glucosyl transfers to the 
glucose at the branching point could then lead to longer 
branches. He also suggested that the enzyme necessary for 
branching could be either the dextransucrase itself, or a 
special branching enzyme. Dextran branching enzymes have 
never been observed^®. 
Ebert and Brosche^® proposed a different mechanism for 
branch formation where a free dextran molecule acts as an 
acceptor releasing dextran from a dextran-dextransucrase 
complex and forming a branch linkage. In their experiment, a 
low molecular weight [^H] dextran was added to sucrose-
dextransucrase digest and found that label incorporated 
into a higher molecular weight dextran. They didn't show that 
the newly formed dextran was synthesized by acceptor reactions 
of the added [^H] dextran. It could have been formed by the 
transfer of glucose units to the nonreducing end of the [^H] 
dextran. They also didn't show that the branch linkage was on 
the acceptor dextran. 
Robyt and Taniguchi^° proposed a mechanism for the 
formation of branch linkages by dextransucrase, giving 
conclusive experimental evidence: Immobilized dextransucrase 
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using 3io-Gel was labeled by incubating it with ['^C] sucrose. 
Extensively washed immobilized dextransucrase was treated with 
a low molecular weight nonlabeled dextran. This process 
released the label from the immmobilized enzyme as ["*"C] 
dextran, but no ["C] dextran was released in buffer alone. 
Structural analysis of the released [-"C] dextran showed that 
it was slightly branched and the acceptor dextran formed an a-
(1^3) branch linkage between a C3-OH on the acceptor dextran 
and the C, of the reducing end of a dextranosyl-dextransucrase 
complex (see Fig. 3). 
In 1978, a general mechanism for the acceptor reactions 
of dextransucrase was proposed by Robyt and Walseth"°. The 
acceptor reactions take place by nucleophilic displacement of 
glucosyl and dextranosyl groups from covalent enzyme-complex 
by a specific hydroxyl group of an acceptor molecule. The 
acceptor reactions stop the dextran chain growth in dextran 
biosynthesis and do not start dextran polymerization by acting 
as primers (see Fig. 3). 
Acceptor reactions 
Dextransucrase synthesizes dextran from sucrose but, in 
the presence of acceptor sugars, some of the glucosyl moieties 
of sucrose are transferred to acceptors forming 
oligosaccharides at the expense of formation of dextran, the 
natural product^^'^^. 
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Dextransucrase 
Sucrose + Acceptor >Acceptor + Dextran + Fructose 
product(s) 
There are more than thirty different acceptors which include 
monosaccharides, oligosaccharides, and polysaccharides". Some 
acceptor products, e.g the acceptor products of maltose and 
isomaltose, themselves act as acceptors and a homologous 
series of acceptor products are formed, while other acceptors, 
e.g D-fructose and lactose, give only a single acceptor 
product"'". 
Robyt and Walseth" studied the mechanism of the acceptor 
reactions using sucrose and "C-labeled acceptors and they 
showed that both glucosyl and dextranosyl groups were 
transferred to the nonreducing end of the acceptors. They 
proposed that the acceptor reactions take place by displacing 
glucosyl and dextranosyl groups from the covalent enzyme-
complex and that the acceptor reactions terminates dextran 
chain growth by displacing it from the active-site. 
Ebert and Schenk" showed that some acceptors increase the 
rate of reaction with B-512F dextransucrase and some decreased 
the rate. Maltose and isomaltose are the most efficient 
acceptors^^. 
The acceptor reactions of dextransucrase with several 
acceptors have been used industrially to produce leucrose", a 
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noncariogenic disaccharide, and controlled molecular weight 
dextrans-"' for medical purposes, such as blood plasma 
substitute. 
Substrate inhibition 
Several researchers observed that dextran synthesis 
follows the Michaelis-Menten equation up to 200 mM sucrose, 
and thereafter the rate of dextran synthesis decreases-"'-'-'-"^. 
Ebert and Schenk-'^ assumed that the decrease of dextran 
synthesis was due to the binding of sucrose to an acceptor 
binding site, where it acts as an acceptor, a weak one. They 
assumed that some enzyme forms an enzyme-acceptor complex with 
sucrose, the rate of dextran synthesis would decrease. 
Stringer and Tsuchiya^® and Neely^®'" also interpreted 
sucrose inhibition as due to binding of sucrose molecules to 
the acceptor sites. Neely^'' further suggested that sucrose 
binds to an acceptor binding site in such a way that no 
reaction occurs. 
Sucrose inhibition was explained by Bovey^"' as the binding 
of a second sucrose molecule to dextransucrase to form an 
inactive dextransucrase-glucosyl-sucrose complex which is 
incapable of synthesizing dextran because of the blocked 
active-site. 
We have recently observed that dextransucrase was almost 
totally inhibited in 2.4M sucrose solution and the enzyme was 
active when sucrose solution is diluted by addition of buffer. 
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PAPER I 
INHIBITION OF DEXTRAN SYNTHESIS BY ACCEPTOR REACTIONS OF 
DEXTRANSUCRASE, AND THE DEMONSTRATION OF A SEPARATE 
ACCEPTOR BINDING-SITE 
Aziz Tanriseven and John F. Robyt 
Laboratory of Carbohydrate Chemistry and Enzymology 
Department of Biochemistry and Biophysics 
Iowa State University 
Ames, Iowa 50 011 
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ABSTRACT 
Hanes-Woolf plots of dextransucrase-sucrose digests with 
methyl a-D-glucopyranoside and with methyl 6-deoxy-a-D-
glucopyranoside showed that they were weak, apparent 
competitive inhibitors with values of 97 and 267 mM, 
respectively; a methyl 6-deoxy-6-fluoro-a-D-glucopyranoside 
plot showed that it was a very weak, noncompetitive inhibitor 
with a Ki of 400 mM. A Michaelis plot with 6-deoxysucrose, a 
known competitive inhibitor with a of 1.6 mM, converged 
with a sucrose plot at 500 mM sucrose. A Michaelis plot with 
methyl a-D-glucopyranoside, a relatively good acceptor but 
poor competitive inhibitor, did not converge with the sucrose 
plot at 600 mM sucrose. Extrapolation of the sucrose and the 
methyl a-D-glucopyranoside plots showed that convergence would 
occur at = 2 M sucrose. Based on its concentration and its K, 
value, the methyl a-D-glucopyranoside plot should have 
converged with the sucrose plot at 200 mM sucrose if it were 
competing with sucrose for the sucrose binding-sites. From 
these observations, it is concluded that methyl a-D-
glucopyranoside does not bind at the sucrose binding-sites 
when it acts as an acceptor, but it binds at a separate 
acceptor binding-site. This is further corroborated by the 
observation that methyl 6-deoxy- and 6-deoxy-6-fluoro-a-D-
glucopyranoside analogues are bound very poorly, whereas the 
corresponding sucrose analogues, 6-deoxysucrose and 6-deoxy-6-
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fluorosucrose are bound approximately ten times more tightly 
than sucrose. The very high concentration of sucrose (= 2M) 
required for the convergence of the methyl a-D-glucopyranoside 
plot with the sucrose plot indicates that sucrose binds only 
very weakly to the acceptor binding-site. 
INTRODUCTION 
Leuconostoc mesenteroides B-512FM dextransucrase (EC 
2.4.1.5) catalyzes the polymerization of the glucosyl moiety 
of sucrose to form dextran, which has 95% a-(l- 6) linkages 
and 5 % a-(l- 3) branch linkages: 
Dextransucrase 
n sucrose > Dextran + n Fructose 
The reaction is essentially nonreversible. a-D-Glucopyranosy 
fluoride* and p-nitrophenyl a-D-glucopyranoside^, are also 
glucosyl donors for the synthesis of dextran by this enzyme. 
The reaction mechanism of dextran formation by 
dextransucrase has been studied by several groups^"^. Robyt e 
al.'^ studied the mechanism by pulse and chase techniques with 
[^^C] sucrose and Bio-Gel P-2 immobilized dextransucrase. They 
found that glucosyl and dextranosyl covalent enzyme complexes 
were formed and that the glucosyl unit was added to the 
reducing end of the growing dextran chain. 
When various carbohydrates are added to a sucrose-
dextransucrase digest, some of the glucosyl groups are 
transferred to the added carbohydrates^'^S which are called 
acceptors. Many different carbohydrates act as acceptors, 
including monosaccharides, oligosaccharides, and 
polysaccharides. In some of these reactions, the acceptor 
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products themselves act as acceptors, and a homologous series 
of acceptor products are formed, whereas other acceptors give 
only a single acceptor-product''". Maltose, isomaltose, and 
methyl a-D-glucopyranoside are examples of acceptors that give 
a homologous series; D-fructose, lactose, and raffinose are 
examples of acceptors that give single products'. 
Using radioactively labeled acceptors such as ['H]methyl 
a-D-glucopyranoside, D-[^H] glucose, D-[^''C] glucose, and D-
[^H]fructose, Ebert and Schenk^ showed that a single acceptor 
molecule was incorporated into a dextran molecule. 
Robyt and Walseth*° studied the mechanism of the acceptor 
reactions by charging the enzyme with sucrose followed by 
reactions with -''C-labeled D-glucose, D-fructose, and maltose 
in the presence and absence of nonlabeled sucrose. Each 
acceptor gave a high-molecular-weight dextran and a low-
molecular-weight saccharide, with the acceptor attached to the 
products at the reducing end. It was proposed that the 
acceptor reaction proceeds by displacing glucosyl and 
dextranosyl groups from the covalent enzyme-complex and that 
the acceptor reaction terminates dextran polymerization by 
displacing it from the active site. 
Robyt and Walseth^° also showed that, for the acceptors 
giving a homologous series of products, the first acceptor 
product was an acceptor to give the second acceptor product, 
which was an acceptor to give the third, etc., with each 
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succeeding acceptor product being produced in a smaller amount 
than was the preceding one. 
Robyt and Taniguchi^^ showed that a similar reaction takes 
place when dextran chains are the acceptor. These 
investigators showed that exogenous dextran displaces dextran 
and glucose from the active site to give a-( 1^3) branch 
linkages between the acceptor dextran and the displaced 
dextran chain and the displaced glucose residue. 
To study the mechanism of the acceptor reaction further, 
we have carried out kinetic studies with methyl a-D-
glucopyranoside, methyl 6-deoxy-a-D-glucopyranoside, and 
methyl 6-deoxy-6-fluoro-a-D-glucopyranoside as acceptors and 
6-deoxysucrose as an inhibitor. 
19 
MATERIALS AND METHODS 
Carbohydrates and reagents 
[U-"C]Sucrose was obtained from Sigma Chemical Co. (St. 
Louis,MO). 6-Deoxysucrose (P-D-fructofuranosyl 6-deoxy-a-D-
glucopyranoside) was synthesized as previously described^^. 
Methyl 6-deoxy-a-D-glucopyranoside was prepared by the 
reduction of methyl 6-chloro-6-deoxy-a-D-glucopyranoside^^ with 
BUjSnH. Methyl 6-deoxy-6-fluoro-a-D-glucopyranoside was 
synthesized by first tritylating and then benzoylating methyl 
a-D-glucopyranoside, followed by the removal of the trityl 
group with acid. The free C-6 hydroxyl group was replaced by 
fluorine by reaction with diethylaminosulfur trifluoride 
(DAST), followed by the removal of the benzoyl groups with 
NaOMe in MeOH. 
Enzyme 
L.mesenteroides B-512FM dextransucrase (EC 2.4.1.5) was 
prepared as previously described . A radiochemical assay^^ 
using [U-^''C] sucrose was used to determine the activity of the 
enzyme. Assays were conducted at 25° and pH 5.3 with 25 mM 
acetate buffer. The amount of labeled glucose incorporated in 
methanol-insoluble dextran was measured. Activity is given in 
International Units (lU), which is the amount of enzyme 
incorporating one /xmol of D-glucose into dextran per min. The 
specific activity of the enzyme was 63 lU /mg of protein. 
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Enzyme digest conditions 
All digests were carried out at 25° in 25 mM acetate 
buffer (pH 5.3) containing 1 mM calcium chloride, 0.1 mg/mL 
sodium azide, and 0.1 mg/mL Tween 80 (refs. 16, 17). 
Digest conditions to obtain Hanes-Woolf plots 
All digests had a total volume of 150 jih. Various sucrose 
concentrations (5, 10, 15, 20, and 25 mM) were used. The 
concentrations of methyl a-D-glucopyranoside and methyl 6-
deoxy-a-D-glucopyranoside were 50 and 100 mM, and the 
concentration of methyl 6-deoxy-6-fluoro-a-D-glucopyranose was 
100 mM. The amounts of enzyme used with methyl a-D-
glucopyranoside, methyl 6-deoxy-a-D-glucopyranoside, and 
methyl 6-deoxy-6-fluoro-a-D-glucopyranoside were 34,17, and 34 
mlU, respectively. The initial velocities were determined by 
taking aliquots at various times (8, 16, 24, and 32 min) and 
the amount of dextran synthesized was measured as a function 
of time. The slope of the resulting line was determined by a 
linear least-squares analysis. 
Digest conditions to obtain Michaelis plots 
All digests had a total volume of 160 /iL. Sucrose 
concentrations of 25, 50, 100, 200, 300, 400, 500, and 600 mM 
were employed. The concentrations of methyl a-D-
glucopyranoside and 6-deoxysucrose were 50 and 2 mM, 
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respectively. The amount of enzyme in both digests was 58 mlU. 
The initial velocities were measured by taking aliquots at 
various times (10,20,30, and 40 min) and determined as already 
described. 
Determination of the amount of dextran synthesized 
Aliquots (25 /xL) were taken from each digest and spotted 
onto Whatman 3MM filter paper squares (1.5 x 1.5 cm). These 
papers were immediately put into MeOH and stirred for 10 min. 
Washing in MeOH was repeated five times to remove any labeled 
D-fructose, D-glucose, unreacted sucrose, and low-molecular-
weight oligosaccharide acceptor-products. A control assay 
using only sucrose was also carried out. The filter papers 
were dried, and a liquid scintillation spectrometer was used 
to count the radioactivity on the papers". For digests with 
sucrose concentrations 200 mM and above, the 25 ixL aliquots 
were added to 0.3 M sodium hydroxide, which was neutralized 
after 60 min to give a 1:5 dilution. This solution (25 /^L) was 
spotted onto paper for counting. The dilution diminishes the 
relatively high concentrations of unreacted sucrose, 
increasing the efficiency of the sucrose removal from the 
paper. The dilution also keeps the amount of dextran 
precipitated on the paper in the proper range^^ for a 
quantitative determination. 
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RESULTS AND DISCUSSION 
The action of dextransucrase can be measured in two 
general ways: (I) by measuring the amount of dextran 
synthesized, as has been done in this study, and (2) by 
measuring the amount of D-fructose formed. The latter is 
attained by either measuring the reducing value, as has been 
used by Koepsell et al.^®, Tsuchiya et al.^®, Ebert and 
Schenk^°, and Bovey^^, or by measuring the D-fructose 
enzymically^^'^\ The reducing value method has its limitations 
in that it not only measures the release of D-fructose, it 
also measures any other reducing compounds that are produced, 
such as D-glucose and reducing acceptor-products. The enzymic 
method also has limitations as it measures both D-fructose and 
D-glucose, and gives low D-fructose values because of the 
action of D-fructose as an acceptor with dextransucrase to 
give leucrose. Within these limitations, the measurement of 
D-fructose gives the approximate determination of the overall 
reaction of sucrose, measuring both the amount of dextran 
synthesized and the amount of acceptor products formed. 
Because the primary reaction of dextransucrase is the 
synthesis of dextran from sucrose, we have measured the rate 
of reaction of dextransucrase by measuring the rate of 
incorporation of D-glucose into dextran^^'^''. We consider that 
this is the best and most specific method for measuring the 
reaction of dextransucrase, and it is especially the best 
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method for determining the effects of acceptors on the 
synthesis of dextran. 
By using the determination of the rate of formation of D-
fructose, several investigators'*'^®'^^ have found that some 
acceptors (such as methyl a-D-glucopyranoside, maltose, and 
isomaltose) produce an increase in the overall rate of 
reaction of sucrose with dextransucrase. In the present study, 
we have found by measuring the rate of dextran synthesis and 
using Hanes Woolf plots (Fig. 1-3) that methyl a-D-
glucopyranoside and methyl 6-deoxy-a-D-glucopyranoside were 
very weak competitive inhibitors, with values of 97 and 267 
mM, respectively, and that methyl 6-deoxy-6-fluoro-a-D-
glucopyranoside was a very weak noncompetitive inhibitor, with 
a Ki value of 400 mM. It was expected that because of its 
structural similarity to the glucopyranosyl moiety of sucrose, 
methyl a-D-glucopyranoside would bind at the sucrose binding 
sites. This also was suggested by the binding of a-D-
glucopyranosyl fluoride at the sucrose site where it acts as a 
substrate (namely, a glucosyl donor) for dextransucrase^. 
If an inhibitor is indeed competing with the substrate for 
the substrate binding site, higher concentrations of the 
substrate should eliminate the inhibition. Michaelis plots of 
the initial velocities of the incorporation of D-glucose into 
dextran versus sucrose concentration in the presence and 
absence of two inhibitors, 6-deoxysucrose and methyl a-D-
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glucopyranoside are given in Fig. 4. This plot shows that the 
rate of dextran synthesis by dextransucrase follows the 
Michaelis-Menten equation up to 200 mM sucrose. Above this 
concentration, the rate of dextran synthesis decreases. This 
was interpreted by Stringer and Tsuchiya^ and Bovey^^ to be due 
to substrate (sucrose) inhibition,and by Ebert and Schenk^ to 
be due to sucrose acting as an acceptor. It is known that as 
the concentration of an acceptor is increased, 
the rate and amount of dextran synthesized is decreased®. 
Alsop^^ has shown that as the concentration of sucrose is 
increased, the concentration of free D-fructose and D-glucose 
is also increased due to their formation by the reaction of 
dextransucrase with sucrose. This increase in the 
concentration of D-fructose and D-glucose produces a 
concomitant decrease in the rate of dextran synthesized 
because of the diversion of the D-glucose moiety of sucrose 
away from its incorporation into dextran, and its 
incorporation into acceptor products by reaction with free D-
fructose and D-glucose acceptors. Thus, it is not only sucrose 
itself that gives the sucrose-dependent inhibition but it is 
the formation of acceptor products as well. It has been 
suggested that sucrose acts as an acceptor and in doing so 
inhibits the synthesis of dextran^. Low-molecular-weight 
sucrose acceptor products, for example, tri-, tetra-, and 
penta-saccharides, however, have never been observed. 
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The Michaelis plot in the presence of 2 mM 6-deoxysucrose, 
a known potent competitive inhibitor with a value of 1.6 mM 
(ref. 25), shows (Fig. 4) that the inhibition is completely-
eliminated at 500 mM sucrose. The Michaelis plot, in the 
presence of 50 mM methyl a-D-glucopyranoside, a relatively 
good acceptor but a poor competitive inhibitor, shows that the 
inhibition is not eliminated at 600 mM sucrose (Fig. 4). 
Extrapolation of the methyl a-D-glucopyranoside and the 
sucrose lines show that they do converge at an extremely high 
sucrose concentration of about 2 M. 
A comparison of the inhibition curves of Fig. 4 for the 
two inhibitors is valid even though the concentrations of the 
two inhibitors were different by a factor of 25; i.e., 50 mM 
for methyl a-D-glucopyranoside and 2 mM for 6-deoxysucrose. 
The Ki values are vastly different - 97 mM for methyl a-D-
glucopyranoside and 1.6 mM for 6-deoxy-sucrose. The ability 
of sucrose to relieve the inhibition depends upon the ratio of 
the inhibitor concentration to the K^, or [I]/Ki. The lower 
the ratio, the easier it is for sucrose to compete with the 
inhibitor and to eliminate the inhibition. In the inhibition 
studies, the ratio for methyl a-D-glucopyranoside was (50:97 = 
0.52) and the ratio for 6-deoxysucrose was (2:1.6 = 1.25). 
Thus, the ratio for methyl a-D-glucopyranoside was 2.5 times 
lower than the ratio for 6-deoxysucrose. If methyl a-D-
glucopyranoside was competing with sucrose for the same 
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binding site, the increase in the sucrose concentration to 200 
mM (500 mM : 2.5) should have eliminated the inhibition as it 
did for 6-deoxysucrose. 
Because an increase in the sucrose concentration 
effectively eliminated the inhibition by 6-deoxysucrose but 
had little effect on the inhibition by methyl a-D-
glucopyranoside, it is concluded that the sucrose analogue, 6-
deoxysucrose, is binding at the sucrose binding site, but the 
acceptor-inhibitor, methyl a-D-glucopyranoside, is not binding 
at the sucrose binding site and, therefore, is binding at a 
separate acceptor binding site. The very high concentrations 
(2 M) of sucrose required to have the methyl a-D-
glucopyranoside and sucrose lines merge further indicates that 
sucrose is weakly binding at the acceptor binding site as was 
previously postulated by Ebert and Schenk^. 
The presence of a separate acceptor binding site is 
corroborated by the very weak competitive inhibition of methyl 
6-deoxy-a-D-glucopyranoside (K^ = 267 mM) and the strong 
competitive inhibition of 6-deoxysucrose (K^ = 1.6 mM) , and 
the very weak noncompetitive inhibition of methyl 6-deoxy-6-
fluoro-a-D-glucopyranoside (K^ = 400 mM) and the strong 
competitive inhibition of 6-deoxy-6-fluoro-sucrose (K^ = 0.8 
mM). If methyl 6-deoxy-a-D-glucopyranoside and methyl 6-deoxy-
6-fluoro-a-D-glucopyranoside were binding at the same site as 
sucrose, it would be expected that they would be as potent 
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inhibitors as are the 6-deoxy- and 6-deoxy-6-fluoro-sucrose 
analogues. Because the methyl a-D-glucopyranoside analogues 
are not strong inhibitors, it can be concluded that they are 
not binding to the sucrose binding site. 
We, therefore, propose that the active-site of L. 
mesenteroides B-512FM dextransucrase has separate sucrose 
binding sites and acceptor binding site(s). A similar 
conclusion was reached by Bovey^^, when he observed the 
activation effects of methyl a-D-glucopyranoside on the 
reaction of dextransucrase with sucrose, by using a reducing 
value method to measure the rates. He further concluded that 
the acceptor does not compete with sucrose but it does compete 
for some intermediate formed later in the process, a 
conclusion that we also make from this study. It is 
reasonable to expect that all of the acceptors should bind at 
the same acceptor binding site, even though they might bind 
with different affinities. Ebert and Schenk^ found that some 
acceptors increased the rate of reaction of sucrose with B-
512F dextransucrase and some decreased the rate. These 
effects were additive when a mixture of acceptors were used, 
indicating that all of the acceptors were binding at the same 
site. Mayer et al.^^ found that methyl a-D-glucopyranoside and 
maltose compete for the same binding site on Streptococcus 
sanguis dextransucrase and suggested that all acceptors are 
binding at this same site. 
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A proposed active-site model for dextransucrase is shown in 
Fig. 5A. In this model there are two sucrose binding sites 
that are required for the synthesis of dextran"' and one 
acceptor binding site. The number of acceptor sites is not 
known, other than there is at least one, but there may be more 
than one. The incorporation of a separate acceptor binding 
site into the model is a refinement of the original acceptor-
mechanism proposed by Robyt and Walseth^°. The acceptor 
binding site is placed between the two X-glucosyl (or 
dextranosyl) groups (see Fig. 5B). The binding of the acceptor 
to the acceptor binding site, would thus, block the insertion 
of the glucosyl residue into the growing dextran chain, giving 
inhibition of the synthesis of dextran and the diversion of 
the glucosyl residue into acceptor products. Similarly, the 
acceptor can also react with the dextranosyl chain (Fig. 5C) 
to release it from the active site and terminate its 
polymerization^". It is further proposed that the acceptor 
binding site has a minimum of two glucosyl subsites as 
maltose, which has two glucosyl moieties, is the most 
effective acceptor^. 
Thus, although such acceptors as methyl a-D-
glucopyranoside and maltose are binding at an acceptor binding 
site rather than at the sucrose binding sites, their kinetic 
effects on the initial velocity of dextran synthesis, at 
relatively low sucrose concentrations, appears to be 
2 9  
competitive with sucrose in a Hanes-Woolf plot or in a 
Lineweaver-Burk plot because they are competing with dextran 
for the glucosyl intermediate that arises from sucrose, 
instead of competing with sucrose for the same binding site. 
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Figure 1. Hanes-Woolf plots of dextransucrase digests 
with a-methyl-D-glucopyranoside. v on the 
Y-axis is reported as /xmol of D-glucose 
incorporated into dextran per minute. 
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Figure 2. Hanes-Woolf plots of dextransucrase digests 
with 6-deoxy-a-methyl-D-glucopyranoside. v on 
the Y-axis is reported as jumol of D-glucose 
incorporated into dextran per minute. 
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with 6-deoxy-6-fluoro-a-methyl-D-glucopyranoside. 
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Figure 4. Michaelis-Menten plots of dextransucrase reaction with 2 mM 
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Figure 5. Model of the active site of Leuconostoc 
mesenteroides B-512FM dextransucrase. 
Symbols: X', catalytic nucleophiles; 
0, glucopyranosyl residues; 0, reducing-end 
glucopyranoside residues; , a-1^6 glycosidic 
bond; — ,a-l-4 glycosidic bond. 
A: active site with two catalytic nucleophiles, 
two sucrose binding sites, and the acceptor binding 
site. 
B: active site showing the glucosyl and 
dextranosyl enzyme complex, an acceptor (maltose) 
in the acceptor binding site, and its reaction with 
the glucosyl complex to give a trisaccharide 
acceptor product. 
C: active site showing the acceptor reaction with 
the dextranosyl complex to give reducing-end 
terminated acceptor dextran product. 
D: active site, without acceptor, showing the 
reaction of the glucosyl residue with the 
dextranosyl unit to give the addition of glucose to 
the reducing-end of the growing dextran chain. The 
sucrose binding sites have been omitted for clarity 
in C and D. 
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ABSTRACT 
When acceptor reactions were carried out at high sucrose 
concentrations (> 200 mM), dextran synthesis was inhibited and 
the acceptor reactions were increased. A model, based on the 
known mechanisms of dextran synthesis and acceptor reactions, 
is proposed to explain the inhibition of dextran synthesis and 
the increase in the acceptor products at high sucrose 
concentrations. According to the model, sucrose binds to a 
third, low affinity binding site, allosterically changing the 
conformation of the active site so that dextran cannot be 
formed but acceptor products can be formed. 
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INTRODUCTION 
Leuconostoc mesenteroides B-512FM dextransucrase 
catalyzes the formation of dextran using the glucosyl part of 
sucrose. B-512F Dextran is a polysaccharide composed of D-
glucose units linked by 95% a-(1-6) linkages and 5% a-(l->3) 
branch linkages. 
It has been shown that dextran synthesis proceeds by a 
two-site insertion mechanism in which glucosyl and dextranosyl 
covalent enzyme intermediates are formed with dextran 
polymerization taking place by the addition of the glucosyl 
unit to the reducing end of the growing dextranosyl chain^. 
When carbohydrates in addition to sucrose are present in 
dextransucrase digests, some of the glucosyl groups of sucrose 
are transferred to the carbohydrates and are diverted from 
entering dextran^'^. These carbohydrates have been called 
acceptors and include several monosaccharides, 
oligosaccharides, and polysaccharides^'®. Some acceptor 
products, e.g., the acceptor products of maltose, isomaltose, 
and methyl-a-D-glucopyranoside, themselves can act as 
acceptors and a homologous series of acceptor products are 
formed^. Some acceptors, such as, D-fructose, lactose, and 
raffinose, give only single acceptor products^'^. 
The formation of acceptor products takes place by the 
acceptor displacing the glucosyl and/or the dextranosyl groups 
from the covalent enzyme - complex''. Using B-512FM 
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dextransucrase, we have shown that the acceptors do not 
compete with sucrose for the sucrose binding-site but bind at 
a separate acceptor binding-site''. It has also been shown in 
our laboratory that the enzyme has two sucrose binding-sites 
and one acceptor binding-site®. 
By measuring either the formation of dextran or the 
release of fructose, it was shown that dextran synthesis 
follows the Michaelis-Menten equation up to 200 mM 
sucrose'''and thereafter the rate of dextran synthesis 
decreases. This decrease was interpreted by Ebert and Schenk^^ 
to be due to the binding of sucrose to an acceptor binding 
site, where it acts as an acceptor. Stringer and Tsuchiya^° 
interpreted sucrose inhibition as a possible competition 
between sucrose and the acceptor, methyl-a-D-glucopyranoside, 
for a putative acceptor-site since methyl-a-D-glucopyranoside 
relieved the inhibition when the amount of fructose released 
was measured. Neely"'^^ also explained the inhibition as due 
to the binding of a second sucrose molecule to dextransucrase-
sucrose complex, in which the enzyme had a greater affinity 
for the first sucrose molecule than for the second sucrose 
molecule, with the second sucrose molecule binding to the 
acceptor-site, thus, inhibiting the reaction. 
Bovey explained the sucrose inhibition as the binding of 
a second molecule of sucrose to dextransucrase to form an 
inactive dextransucrase-glucosyl-sucrose complex^^ although no 
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evidence was presented. 
The present work was undertaken to explain sucrose 
inhibition of dextransucrase because of the various 
interpretations that have been proposed with essentially the 
absence of supporting evidence. 
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EXPERIMENTAL 
Chromatography 
Thin layer chromatography (TLC) was conducted on Whatman 
K5 plates using three ascents of solvent 1, acetonitrile/water 
85:15 (v/v) and/or three ascents of solvent 2, 
nitromethane/water/l-propanol 2:3:5 (v/v/v) and two ascents of 
solvent 3, acetone/choloroform/water 85:10:5 (v/v/v). The 
carbohydrates were visualized by dipping the plates into 5% 
(v/v) sulfuric acid in ethanol containing 0.5% thymol and 0.5% 
a-naphtol or 20% (v/v) sulfuric acid in methanol, followed by 
heating for 10 minutes at 110 °C. The sulfuric acid in 
methanol system was used only for the determination of 
dextran. 
Enzyme 
L•mesenteroides B-512FM dextransucrase was prepared as 
previously described^®. The activity of the enzyme was 
determined by a radiochemical assay^'' using [U-^^C] sucrose. 
Assays were conducted at 25°C and pH 5.4 with 25 mM acetate 
buffer containing 1 mM calcium chloride, 0.1 mg/ml sodium 
azide, and 0.1 mg/ml Tween 80. The amount of radioactive 
glucose incorporated into methanol insoluble dextran was 
determined by liquid scintillation spectrometry. The activity 
is given in international units (lU), i.e., the amount of 
enzyme necessary to incorporate one /i mol of D-glucose into 
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dextran in one minute. The activity of the enzyme used was 
120 lU/ml and the specific activity was 90 lU/mg of protein. 
Enzyme-digest conditions 
The following digests containing 2.4 lU dextransucrase in 
25 mM acetate buffer(pH 5.4) were prepared: 
Digest 1: 5 ml of 50 mM sucrose; 
Digest 2: 5 ml of 50 mM sucrose containing 50 mM methyl-a-D-
glucopyranoside ; 
Digest 3: 0.5 ml of 500 mM sucrose; 
Digest 4: 0.5 ml of 500 mM sucrose containing 500 mM methyl-a-
D-glucopyranoside . 
The reactions were carried out at room temperature (23°C) 
for 4 hours. TLC, using solvent 1, showed that all the 
sucrose had been converted into products. At the end of the 
reaction, digests 3 and 4 were added to 4.5 ml of acetate 
buffer so that all of the digests had the same final volume (5 
ml) for analysis of the products. 
The amounts of dextran formed, using solvent 2, and 
remaining methyl-a-D-glucopyranoside,using solvent 3, in the 
digests were determined by TLC densitometry (Uniscan , 
Analtech,Inc Newark,DE). Dextran with a molecular weight of 
10,500 (Sigma, St.Louis, MO) was used as standards for the 
determination of dextran. 
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RESULTS 
Fig. 1 shows the TLC of the reaction digests. Using TLC 
densitometry, the reaction digests were analyzed as shown in 
Table I and the results are as follows. All the glucosyl 
units of sucrose were incorporated into dextran when 50 mM 
sucrose (Digest 1) was used. In digest 2 (50 mM sucrose and 
50 mM methyl-a-D-glucopyranoside), 77.6% of the glucosyl 
units of sucrose were incorporated into dextran and 22.4% of 
the glucosyl units were transferred to acceptors. When 500 mM 
sucrose (Digest 3) was used, 94.2% of the glucosyl units of 
sucrose were incorporated into dextran and the remaining 
(5.8%) were transferred to fructose, the by-product of the 
reaction, to form leucrose. In digest 4 (500 mM sucrose and 
500 mM methyl-a-D-glucopyranoside), almost all of the glucosyl 
units of sucrose (95.0%) were transferred to acceptors, and 
there was only a small amount (5.0%) of dextran formed. 
To determine the effect of the sucrose concentration on 
the acceptor reactions, we have used the same amounts of 
enzyme, sucrose, and methyl-a-D-glucopyranoside in Digests 2 
and 4 and found that only 7.6% of the methyl-a-D-
glucopyranoside reacted in Digest 2, which consisted of 5 ml 
of 50 mM sucrose and 50 mM methyl-a-D-glucopyranoside, but 
38.6% of the methyl-a-D-glucopyranoside reacted in Digest 4, 
which consisted of 0.5 ml of 500 mM sucrose and 500 mM methyl-
a-D-glucopyranoside. This result showed that even though the 
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amounts of sucrose, acceptor, and enzyme were the same in the 
two digests, there was more acceptor products formed in Digest 
4 in which the concentration of sucrose was high and the 
sucrose was inhibiting dextran synthesis. 
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DISCUSSION 
It has been shown by several studies that the rate of 
dextran formation decreases if the sucrose concentration is 
greater than 200 Alsop^® reported that the size and 
the amount of dextran synthesized by dextransucrase is 
dependent primarily on the initial concentration of sucrose. 
When 2% w/v (58 mM) sucrose was used, almost all of the 
glucosyl groups of sucrose were incorporated into high 
molecular weight dextran, but when the concentration of 
sucrose was increased, the amount and molecular weight of 
dextran decreased and some oligosaccharides were formed. The 
amount of D-glucose, which is obtained when water acts as an 
acceptor, also increased. These changes were much more 
obvious at sucrose concentrations greater than 200 mM in which 
the rate of dextran formation decreased as the sucrose 
concentration increased. 
Tsuchiya^® used 70% (2 M) sucrose and found that the 
products were mostly oligosaccharides, with some low molecular 
weight dextran (^35,000 Da), and no high molecular weight 
dextran. 
Our results confirmed that the amount of dextran 
synthesized depends on the sucrose concentration in which 
concentrations greater than 200 mM give lower amounts of 
dextran. Our results also show that acceptor reactions are not 
affected by high sucrose concentrations. 
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At high sucrose concentrations in the presence of 
equimolar amounts of good acceptors, such as methyl-a-D-
glucopyranoside or maltose, dextransucrase does not catalyze 
the synthesis of dextran but does catalyze the synthesis of 
acceptor-products. For example, 500 mM sucrose in the 
presence of 500 mM methyl-a-D-glucopyranoside, dextransucrase 
gave very small amounts of dextran and transferred most of the 
glucose units of sucrose to methyl-a-D-glucopyranoside and 
subsequent acceptor-products (Fig. 1). At an identical ratio 
of 1:1 acceptor to sucrose but at a concentration of 50 mM, 
instead of 500 mM, acceptor products were produced along with 
dextran. Similar results have been obtained using sucrose and 
maltose^°. 
Ebert and Schenk^^, Stringer and Tsuchiya^°, and Neely"'''^^ 
each interpreted the sucrose inhibition of dextransucrase by 
high sucrose concentration (i.e.,^ 200 mM) as the binding of 
sucrose at the acceptor binding-site. Their interpretations 
do not explain the increase in acceptor reactions that occur 
at high sucrose concentrations. 
Bovey^^ postulated that dextran synthesis occurs by the 
formation of a glucosyl-enzyme complex in which the glucose is 
transferred to a primer. He also postulated that acceptor 
reactions occur by a different route in which the acceptor 
reacts with an enzyme-sucrose complex instead of an enzyme-
glucosyl complex. Both of these proposed mechanisms have been 
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shown by Robyt et al. ^ and Robyt and Walseth^ to be incorrect. 
Based on these incorrect mechanisms, Bovey^^ interpreted 
inhibition by high sucrose concentrations as the result of 
sucrose reversibly binding to the enzyme-glucosyl complex, 
which is the first step in his mechanism of dextran synthesis. 
This dextransucrase-sucrose-glucosyl complex was postulated to 
be incapable of further reaction because the sucrose was 
blocking the active-site. Bovey then proposed that the reason 
acceptor reactions were not affected by high sucrose 
concentrations was because they were occuring through an 
enzyme-sucrose complex that could not react with a second 
sucrose molecule. 
In view of what is now known about the mechanisms of 
dextran synthesis^ and acceptor reactions^ of dextransucrase, 
we propose the following model to explain the simultaneous 
sucrose inhibition of dextran synthesis and the increased 
synthesis of acceptor products at high sucrose concentrations. 
It is known that the active site of dextransucrase has two 
high affinity sucrose binding-sites^'® and one acceptor 
binding-site®. Acceptors can bind in the acceptor-site and 
react with either the glucosyl or the dextranosyl groups that 
are covalently attached to the X-nucleophilic groups at the 
enzyme active-site''. Sucrose does not bind in the acceptor 
binding-site, even at very high sucrose concentrations''. At 
high sucrose concentrations (i.e. above 200 mM), it is 
52 
proposed that sucrose binds at a low affinity, third sucrose 
binding-site, that allosterically changes the conformation of 
the active-site (see B in Fig.2). This allosteric binding 
does not affect the binding of sucrose at the sucrose binding 
sites nor does it affect the formation of glucosyl-enzyme 
covalent complexes. The binding of sucrose in the allosteric 
site changes the conformation of the active-site in such a way 
as to prevent the interaction of the two glucosyl groups to 
give dextran elongation. The allosterically inhibited enzyme, 
however, still allows an acceptor to bind at the acceptor 
binding-site and interact with one of the glucosyl-enzyme 
complexes to give acceptor products (see Fig. 2 B and C). 
Methyl-a-D-glucopyranoside and the subsequent acceptor 
products, which are mainly produced by allosterically 
inhibited dextransucrase, release glucosyl units from both the 
uninhibited dextransucrase and the allosterically inhibited 
dextransucrase. This explains the incorporation of almost all 
the the glucosyl units of sucrose into acceptor products, 
rather than into dextran in the digest containing 500 mM 
sucrose and 500 mM methyl-a-D-glucopyranoside. 
At high sucrose concentrations, in the absence of 
acceptors, the allosterically inhibited enzyme can still form 
dextransucrase-glucosyl complexes, but it does not synthesize 
dextran due to the change in the conformation of the active-
site (Fig. 2 B). In the absence of acceptors, the glucosyl 
53 
units can be released by acceptor reactions with water. This, 
thus, explains the observed increase in D-glucose when the 
sucrose concentrations are greater than 200 . The increase 
in the amounts of D-glucose, along with the concomitant 
presence of D-fructopyranose, provide acceptors that also can 
release D-glucose from the active-site and form 
oligosaccharides that were observed by Alsop^® and Tsuchiya". 
In summary, then, the sucrose allosteric inhibition of 
dextransucrase explains all of the observed effects of high (> 
200 mM) sucrose concentrations: namely, the inhibition of 
dextran synthesis, the increase in the formation of acceptor 
products, and the increase in the formation of D-glucose and 
oligosaccharides. 
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Table I. Percentages of the total D-glucose from sucrose in 
products of Leuconostoc mesenteroides B-512FM Dextransucrase 
Digests 
Digests^ % Dextran % Acceptor product(s) 
1. 5 mL 50 mM sucrose 100 0 
2. 5 mL 50 mM sucrose + 
50 mM methyl-a-D- 78 22 
glucopyranos ide 
3. 0.5 mL 500 mM sucrose 94 6 
4. 0.5 mL 500 mM sucrose 
+ 500 mM methyl-a-D-
glucopyranoside 5 95 
^ Each digest contained 2.4 lU of enzyme. 
Figure 1. TLC analysis of dextransucrase digests with 
different amounts of sucrose and methyl-a-D-
glucopyranoside. 
Lane 1: 50 mM sucrose digest 
Lane 2: 50 mM sucrose + 50 mM methyl-a-D-
glucopyranoside digest 
Lane 3: 500 mM sucrose digest 
Lane 4:500 mM sucrose and 500 mM methyl-a-D-
glucopyranoside digest 
Lane 5:Methyl-a-D-glucopyranoside, fructose, glucose 
and sucrose standards 
Lane 6: Isomaltodextrin series standards 
IMn: Isomaltodextrins of d.p. n 
APn: Acceptor product where n represents first, 
second, third, etc. product formed. 
a-Me-Glc: Methyl-a-D-glucopyranoside 
Glc: Glucose 
Fru: Fructose 
Sue: Sucrose 
Leu: Leucrose 
TLC was run on Whatman K5 plates using three ascents of 
solvent 2 up to the middle of the plate, and then three 
ascents of solvent 1. 
a-Me-Glc! of-Me-Glc 
Fru 
API 
Leu 
AP2 
AP3 
AP4 
APS 
AP6 
AP7 
APS 
<|P 
mm 
m 
Fru 
Glc 
Sue 
IM2 
IMS 
IM4 
IMS 
IM6 
IM7 
IMS 
1 2 3 4 6 
Dextran 
Fig.2 Model for inhibition of L.mesenteroides B-512FM 
dextransucrase by high sucrose concentrations. 
A, fully active uninhibited dextransucrase active-site, 
showing two high affinity sucrose binding-sites (b and b'), a 
lower affinity allosteric sucrose binding-site (c), and an 
acceptor binding-site (a); B, allosterically inhibited 
dextransucrase by high sucrose concentration in which the 
conformation of the active-site has been changed so that 
dextran synthesis cannot occur; C, acceptor reaction of 
allosterically inhibited dextransucrase in the presence of 
methyl-a-D-glucopyranoside acceptor and the formation of 
acceptor-product, methyl-a-isomaltoside. 
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ABSTRACT 
We have produced a sugar mixture containing isomalto­
dextrins, fructose, glucose, and leucrose using a new 
technique. Sucrose was first treated with yeast invertase to 
obtain invert sugar, a mixture of fructose and glucose. After 
inactivating the invertase, the invert sugar was added to 
sucrose and reacted with Leuconostoc mesenteroides B-512FM 
dextransucrase to produce isomaltodextrins and leucrose. 
Depending upon the molar ratio of invert sugar to sucrose, 
isomaltodextrins with different degree of polymerization (DP) 
were obtained. 
This sugar mixture can be produced in large quantity very 
cheaply and could find many uses in the food industry due to 
its sweetness and health benefits. Isomaltodextrins are known 
to enhance the Bifidobacterium, beneficial bacteria, that are 
naturally found in the human large intestine. 
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INTRODUCTION 
Sucrose is the most commonly used sweetener. It, 
however, contributes significantly to the formation of dental 
plague and caries^'^. Some of the glucose of sucrose is 
converted into glucan by Streptococcus mutans in the oral 
cavity. This glucan binds to teeth and aids in the adhesion 
of Streptococcus mutans to teeth surfaces. The resulting 
fructose is fermented to lactic acid by these bacteria and 
this acid is held close to teeth surfaces, where it attackes 
the enamel, leading to dental caries. Restricting sucrose in 
diet does decrease the numbers of Streptococcus mutans in the 
dental plaque^''' . 
Several kinds of new sugars have been developed to 
prevent tooth decay. Sucrose was converted into 
isomaltulose^, using immobilized a-glucosyltransferase from 
Protaminobacter rubrum. This sugar does not cause tooth decay 
and has 42% of the sweetness of sucrose. Leucrose also has 
been produced using sucrose, fructose, and dextransucrase®"®. 
Leucrose, a-D-glucopyranosyl (l-'5)-D-fructopyranose, is a non-
cariogenic sugar with a sweetness about 50 to 60 % that of 
sucrose. Leucrose is not fermented by several kinds of oral 
microorganisms and inhibits the uptake and fermentation of 
sucrose by Streptococcus mutans NCTC 10449®. 
It has been found that several different kinds of 
carbohydrates will enhance the growth of Bifidobacteria in the 
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human large intestine^"'". The Bifidobacteria occur naturally 
in the human intestine and contribute many healthful 
benefits^^'^®, including synhesis of B-comlex vitamins, 
reduction in serum cholesterol, anticarcinogenic effect, and 
resistance to some infections. One of the carbohydrates 
enhancing the Bifidobacteria is 6'-galactosyllactose, which is 
present in human milk. This sugar promoted the growth of 
piglets and could be used in infant formula and animal feed. 
It has been produced synthetically using lactose and p-
galactosidase in Japan^®. It was also shown in France that 
when pigs were fed with oligosaccharides which can reach large 
intestine without being digested in small intestine, the pigs 
were significantly heavier than the control pigs. The average 
weight increase over the controls was 9% in three months. It 
is thought that these oligosaccharides enhance the beneficial 
bacteria, Bifidobacteria, in the colon^''. 
There are two ways to increase the number of Bifidobac­
teria : (a) having bifid-amended foods and beverages, which 
is becoming common in Japan and Europe^^; there are also some 
US milk companies that are adding live Bifidobacteria to their 
dairy products, and (b) eating specific carbohydrates that 
promote the growth of Bifidobacteria in the large intestine. 
The carbohydrates that enhance the Bifidobacteria in the 
human intestine include isomaltodextrins^°"^^, fructo-
oligosaccharides^°'^^, and galactooligosaccharides^°. 
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Isomaltodextrins selectively promote the growth of 
Bifidobacteria and thereby inhibit the growth of harmful 
bacteria, such as Clostridia that cannot use them". When rats 
were given drinking water with 3% isomaltodextrins , no 
adverse biochemical effects were observed, and mutagenicity 
tests using bacteria were negative^®. It was also shown by 
another study that the levels of serum triacylglycerol and 
free fatty acids were significantly lower when isomaltodex­
trins or fructooligosaccharides were ingested than it was when 
sucrose or maltose were ingested^". Isomaltodextrins also 
reduce the harmful cariogenic effects of sucrose, when sucrose 
and isomaltodextrins are consumed together^^'^^. Further, it 
has been shown that isomaltodextrins increase B-lymphocytes, 
thus, helping the immune system fight against infection^^. It 
was also found that solutions composed of isomaltodextrins can 
be administered intraveniously to humans to prevent the 
dextran-antibody precipitation reaction, which is observed in 
about 5% when a solution of dextran is given to humans as a 
plasma substitute^"^. 
A health drink, containing isomaltodextrins as a 
sweetening agent, has been patented for its promotion of 
bifidus bacteria in the large intestines. It has been claimed 
that the drink is especially good for infants, the elderly, 
and the ill patients^^. Several food preparations, containing 
isomaltodextrins also have been patented in Japan^®-^''. Animal 
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feeds containing isomaltodextrins as an additive have also 
been prepared in Japan^®. 
Using sugars in food preparations that are enhancers for 
the Bifidobacteria and have no cariogenity and are not caloric 
will be very beneficial. 
We have developed a process by which it is possible to 
produce healthful sugar mixtures using sucrose, yeast inver-
tase, and Leuconostoc mesenteroides B-512FM dextransucrase. 
The components of the sugar mixture are fructose,glucose, 
leucrose, and isomaltodextrins. The reactions taking place 
during the process are shown in Fig. 1. First sucrose is 
hydrolyzed by yeast invertase to glucose and fructose, then 
sucrose and dextransucrase are added to produce leucrose and a 
mixture of isomaltodextrins. This mixture of sugars could 
have many health benefits to man as the isomaltodextrins are 
Bifidobacteria enhancers, and leucrose is a noncariogenic 
sweetener. Fructose and glucose are also sweet and do not 
contribute to the formation of dental plaque, a prequiste for 
tooth decay. The sugar mixture can be produced on a large 
scale, inexpensively by using immobilized invertase and 
dextransucrase. As indicated above this sugar mixture can 
find many applications. It could replace sucrose in some food 
preparations and high fructose corn syrup. 
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EXPERIMENTAL 
Chromatography 
Thin layer chromatography (TLC) was performed on Whatman 
K5 silica gel plates (Whatman Chemical Separatins, Inc., 
Clifton, NJ). TLC plates were developed in one of the 
following solvent systems: (A) acetonitrile/water 85:15 (v/v) 
or (B) nitromethane/water/l-propanol 2:3:5 (v/v/v). The 
carbohydrates were visualized by dipping the plates into a 
solvent system composed of 5% sulfuric acid, and 0.5% a-
naphthol in ethanol, followed by heating for 10 minutes at 
120°C. 
Enzymes 
Leuconostoc mesenteroides B-512FM dextransucrase was 
prepared as previously described^®. Dextransucrase activity 
was determined by a radiochemical assay^® using [U-"C] sucrose 
and is given in International Units, lU, which is the amount 
of enzyme necessary to incorporate 1 /i mole of D-glucose from 
sucrose into dextran in 1 minute at pH 5.4 and 25°C. The 
activity of dextransucrase was 42 lU/ml. Yeast invertase 
(grade V) was purchased from Sigma Chemical Co., St. Louis, 
MO. and had an activity of 3 0 units/mg. One unit of 
Invertase hydrolyzes one ix mole of sucrose to glucose and 
fructose in one minute at pH 4.5 at 55°C. 
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Preparation of sugar mixtures containing 
isomaltodextrins from sucrose 
Sucrose solution (1.5 M), prepared using 5 g of sucrose 
and 25 mM acetate buffer (pH 5.4), was reacted with 50 mg of 
yeast(Saccharomyces cerevisiae) invertase at room temperature 
(23°C) for one hour. TLC (two ascents of solvent A) showed 
that the reaction was complete. Invertase was inactivated by 
heating at 95°C for 20 minutes. Invert sugar solution was 
added to sucrose, followed by dextransucrase to obtain two 
different digests (6 mL total volume each). The first digest 
consisted of 0. 5iyi invert sugar, IM sucrose, and 3 0 lU 
dextransucrase. The second digest consisted of IM invert 
sugar, IM sucrose, and 3 0 lU dextransucrase. The reactions 
were allowed to go for 16 hours at room temperature (23°C) . 
TLC (two ascents of solvent A) showed that all of the sucrose 
had been consumed. The components of the two digests were 
analyzed by TLC (10x20 cm Whatman K5 plate, by first using 
three ascents of solvent B up to two thirds of the plate 
followed by four ascents of solvent A to the top of the plate) 
(See Fig. 2). The amount of each carbohydrate in the two 
digests was determined using an imaging densitometer (Bio-Rad 
Laboratories , Inc., Hercules, CA) and standards (fructose and 
glucose). 
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RESULTS AND DISCUSSION 
The results are shown in Table I. Digest I had fructose, 
glucose, leucrose, and isomaltodextrins up to DP of 12. 
Digest II had fructose, glucose, leucrose, and 
isomaltodextrins up to DP of 6. 
Isomaltodextrins have been produced by using different 
methods and carbohydrates such as starch^°'^^, glucose^^, 
maltose^^, dextran^^'^^, and sucrose along with glucose^^. Starch 
is treated first with thermostable bacterial a-amylase, then a 
mixture of soybean P-amylase and Aspergillus niger 
transglucosidase, a type of a-glucosidase. The sugar mixture 
contains glucose, maltose, and isomaltodextrins. This sugar 
mixture is used presently as a syrup in soft drinks, 
confectionery products, bakery goods, and several other food 
preparations". In a recently developed method in Japan, 
bacterial saccharifying a-amylase from BaciXIus subtilis and 
neopullulanase are added to a gelatinized starch solution^^. 
The resulting syrup consisted of glucose, maltose, panose, and 
isomaltodextrins. Glucose or maltose and cellulase from 
Aspergillus niger were also used for the production of 
isomaltodextrins^^. A novel endodextranase from Fusarium sp", 
and an exo-type dextranase from Arthrobacter i aponicus^*^ were 
used to produce isomaltodextrins from dextran. These 
preparations, however, are all quite expensive. Sucrose along 
with glucose and dextransucrase have also been reported for 
70 
the synthesis of isomaltodextrins^^. In our new method, we use 
sucrose, yeast invertase, and L- mesenteroides B-512FM 
dextransucrase for the production of sugar mixtures containing 
isomaltodextrins. The cost involved in the process is quite 
low. Yeast invertase, one of the enzyme used, is a 
thermostable enzyme and has been produced industrially on a 
large scale^® and is very inexpensive. Even whole yeast cells 
can be used as invertase after a short heat treatment or a 
brief contact with concentrated ethanol". We have shown that 
whole yeast cells can be used as invertase: 1 g of 
Fleischmann's yeast was suspended in 4 mL of distilled water 
and kept in a water bath at 70°C for four minutes, then cooled 
in a ice-water bath. These heat treated yeast cells were non­
viable and incapable of fermenting glucose and fructose, but 
they had invertase activity, Dextransucrase, the second 
enzyme used in the process, is also an industrially important 
enzyme and is produced on a large scale. We have successfully 
immobilized dextransucrase and invertase and used them for the 
production of isomaltodextrins. The product distribution was 
similar to those obtained using the soluble enzymes. 
The sugar mixture obtained from our process has 
isomaltodextrins, fructose, glucose, and leucrose. The sugar 
mixture is sweet due to the presence fructose, glucose, and 
leucrose, and has the many health benefits of 
isomaltodextrins. It can be produced cheaply on a large scale 
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and has potential use in soft drinks and many other food 
preparations that could be marketed as a health food. 
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Figure 1. Reactions taking place for the production of 
sugars containing isomaltodextrins from sucrose 
using yeast invertase and dextransucrase. 
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Table I. Percentage of carbohydrates in Digest and Digest 
Carbohydrate Digest I Digest II 
Fructose 52 . 1^= 50 . 9= 
Glucose 13 .3 19 . 0 
Leucrose 9.4 9 . 6 
Isomaltose 2 . 7 5 . 1 
Isomaltotriose 2 . 5 5 . 4 
Isomaltotetraose 3.5 5 . 5 
Isomaltopentaose 4 . 2 3 . 5 
Isomaltohexaose 3.3 1 .1 
Isomaltoheptaose 2 . 8 -
Isomaltooctaose 2.2 -
Isomaltonanoose 1. 7 -
Isomaltodecaose 
and bigger 2.3 -
^Digest I consisted of 0.5M invert sugar, IM sucrose, and 
Dextransucrase (30 lU). 
''Digest II consisted of IM invert sugar, IM sucrose, and 
Dextransucrase (30 lU). 
•^Percentages determined by quantitative TLC, using an imaging 
densitometer. 
Figure 2. TLC analysis of dextransucrase digests 
Lane 1: Digest I, 0.5M invert sugar + IM sucrose 
Lane 2; Digest II, IM invert sugar + IM sucrose 
Lane 3: Fructose, glucose, and sucrose standards 
Lane 4: Isomaltodextrins standarts 
Fru: Fructose 
Glc: Glucose 
Sue: Sucrose 
Iso: Isomaltulose 
Leu: Leucrose 
IMn: Isomaltodextrins of dp n 
TLC was run on Whatman K5 plate using three ascents 
of solvent B up to two thirds of the plate, and 
then four ascents of solvent A to the top of the 
plate. 
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IM2 
IM3 
IM4 
IMS 
IM6 
IM7 
IMS 
IM9 
Fru 
GIc 
Sue 
IM2 
IM3 
IM4 
IMS 
IM6 
IM7 
IMS 
IM9 
r'f'. * 
1 2 3 4 
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GENERAL SUMMARY 
When acceptors and sucrose are present in a digest, 
dextransucrase carries out two different reactions, dextran 
synthesis and formation of oligosaccharides by transfer of 
glucose units to the nonreducing end of acceptors. During the 
acceptor reactions, it was natural to assume that the 
acceptors compete with sucrose for the sucrose binding-site 
because of the structural similarities between sucrose and the 
acceptors such as glucose, maltose, and methyl a-D-
glucopyranoside. Although Hanes-Woolf plot showed that methyl 
a-D-glucopyranoside was an apparent competitive inhibitor for 
dextransucrase, a Michaelis-Menten plot using methyl a-D-
glucopyranoside in the presence of high concentration of 
sucrose showed that it was not a real competitive inhibitor. 
We have also found that methyl 6-deoxy-a-D-glucopyranoside and 
methyl 6-deoxy-6-fluoro-a-D-glucopyranoside were weak 
inhibitors, whereas the corresponding sucrose analogues 6-
deoxysucrose and 6-deoxy-6-fluorosucrose are very potent 
inhibitors for dextransucrase. From these findings, it is 
concluded that the acceptor, methyl a-D-glucopyranoside, does 
not compete with sucrose for the sucrose binding-sites and it 
binds at a separate acceptor binding-site. 
Dextran synthesis follows Michaelis-Menten equation up to 
200 mM sucrose concentration. At high sucrose concentrations 
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(^200 mM), the rate of dextran formation decreases and 
acceptor reactions are increased. We have proposed a model to 
explain the inhibition of dextran synthesis and the increase 
in the acceptor products at high sucrose concentrations. 
According to the model, sucrose binds to a third low-affinity 
binding-site changing the conformation of the active site so 
that dextransucrase cannot synthesize dextran but can carry 
out acceptor reactions to form oligosaccharides. 
Isomaltodextrins are known enhancers of Bifidobacteria.a 
beneficial bacteria naturally found in human large intestine. 
We have developed a new method for the preparation of sugar 
mixtures containing isomaltodextrins. Invert sugar, obtained 
by hydrolysis of sucrose by yeast invertase, was added to 
sucrose and dextransucrase to synthesize leucrose and 
isomaltodextrins. 
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